Atlas Trials

Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Clinical trial NCT02381015 · COMPLETED

Trial details

NCT number
NCT02381015
Sponsor
Endeavor Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate CancerProstate Cancer, FamilialHereditary Prostate Cancer
Start date
2011-06-01
Primary completion
2012-06-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.